Key result
Epac1 deficiency cuts vascular smooth muscle cell migration ~40% and reduces neointima formation in mice.
Answers are grounded in this paper and cite their sources.
Demonstrates that Epac1 deficiency attenuates vascular smooth muscle cell migration and neointima formation in mice, suggesting a therapeutic target for vascular remodeling.
OBJECTIVE: Vascular smooth muscle cell (SMC) migration causes neointima, which is related to vascular remodeling after mechanical injury and atherosclerosis development. We previously reported that an exchange protein activated by cAMP (Epac) 1 was upregulated in mouse arterial neointima and promoted SMC migration. In this study, we examined the molecular mechanisms of Epac1-induced SMC migration and the effect of Epac1 deficiency on vascular remodeling in vivo. APPROACH AND RESULTS: Platelet-derived growth factor-BB promoted a 2-fold increase in SMC migration in a primary culture of aortic SMCs obtained from Epac1(+/+) mice (Epac1(+/+)-ASMCs), whereas there was only a 1.2-fold increase in Epac1(-/-)-ASMCs. The degree of platelet-derived growth factor-BB-induced increase in intracellular Ca(2+) was smaller in Fura2-labeled Epac1(-/-)-ASMCs than in Epac1(+/+)-ASMCs. In Epac1(+/+)-ASMCs, an Epac-selective cAMP analog or platelet-derived growth factor-BB increased lamellipodia accompanied by cofilin dephosphorylation, which is induced by Ca(2+) signaling, whereas these effects were rarely observed in Epac1(-/-)-ASMCs. Furthermore, 4 weeks after femoral artery injury, prominent neointima were formed in Epac1(+/+) mice, whereas neointima formation was significantly attenuated in Epac1(-/-) mice in which dephosphorylation of cofilin was inhibited. The chimeric mice generated by bone marrow cell transplantation from Epac1(+/+) into Epac1(-/-) mice and vice versa demonstrated that the genetic background of vascular tissues, including SMCs rather than of bone marrow-derived cells affected Epac1-mediated neointima formation. CONCLUSIONS: These data suggest that Epac1 deficiency attenuates neointima formation through, at least in part, inhibition of SMC migration, in which a decrease in Ca(2+) influx and a suppression of cofilin-mediated lamellipodia formation occur.
No takes yet. Share an insight, caveat, or question.
Kato et al. (2015) studied Vascular remodeling and neointima formation after femoral artery injury. Epac1 deficiency (Epac1-/-) vs. Wild-type (Epac1+/+) was evaluated on PDGF-BB-induced vascular smooth muscle cell migration and in vivo neointima formation. Epac1 deficiency attenuated PDGF-BB-induced smooth muscle cell migration and reduced neointima formation 4 weeks after femoral artery injury in mice.
Synapse has enriched 10 related papers. Consider them for comparative context: